CTNND1 and non-small cell lung carcinoma: Having observed that the expression of CTNND1 in the immunotherapy sensitive group was significantly lower than that in the ineffective group, we next sought to investigate the correlations between CTNND1 expression and the TME status of the NSCLC patients.